We turn futuristic science into next-generation
businesses that benefit the planet.

Our Story

Bionatus, LLC, focuses on developing breakthrough scientific discoveries into successful end-stage businesses with significant global impact. Occupying a unique role as both the founders and co-executives of our companies, we provide strategic and business development oversight while maintaining guiding principals that are focused above and beyond just financial return, rooted in delivering technologies that benefit humanity and the environment. Bionatus, LLC, is a certified Benefit Corporation.


Bluon, Inc. is rapidly becoming America’s leading HVAC retrofit solutions company. Bluon developed R-458A refrigerant (the energy saving solution for the R-22 phaseout), offers retrofit solutions to corporate clients, and provides industry first technology solutions to its nationwide network of Bluon Accredited HVAC contractors.

Luminas Energy, LLC is a fast growing consumer health technology company, and a first mover in the new field of “elecroceuticals.” Luminas has developed a suite of groundbreaking wearable patches that deliver remarkable benefits without drugs, chemicals, or side effects, including Luminas Relief (a pain relief patch) and StaminaPro (an athlete-endorsed recovery and performance patch).
www.luminas.com  and  www.staminapro.com

ThrivalTech, LLC is a pioneer in the application of non-thermal plasma for large-scale industrial problem solving, including mitigating emissions and improving performance within internal combustion engines. In many cases, ThrivalTech has developed the first viable plasma solutions for applications previously thought impossible. ThrivalTech is currently in stealth mode.

RevX Technologies, Inc. is a leading developer of acoustic technologies that solve critical issues in consumer audio products, and pushes the boundaries of what is possible in audio chipsets and headsets, from noise cancellation to new techniques in spatial audio.

Bionatus has a portfolio of other companies and core IP still in R&D mode.


For investors and those seeking more information:
Peter Capuciati | [email protected] | 917-749-9570

Contact Us